These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 32893454)

  • 1. Multifaceted HIV-1 Vif interactions with human E3 ubiquitin ligase and APOBEC3s.
    Hu Y; Knecht KM; Shen Q; Xiong Y
    FEBS J; 2021 Jun; 288(11):3407-3417. PubMed ID: 32893454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Core binding factor beta plays a critical role by facilitating the assembly of the Vif-cullin 5 E3 ubiquitin ligase.
    Fribourgh JL; Nguyen HC; Wolfe LS; Dewitt DC; Zhang W; Yu XF; Rhoades E; Xiong Y
    J Virol; 2014 Mar; 88(6):3309-19. PubMed ID: 24390320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dominant Negative Mutants of Human Immunodeficiency Virus Type 1 Viral Infectivity Factor (Vif) Disrupt Core-Binding Factor Beta-Vif Interaction.
    Duan S; Yu X; Wang C; Meng L; Gai Y; Zhou Y; Gu T; Yu B; Wu J; Yu X
    J Virol; 2022 Sep; 96(17):e0055522. PubMed ID: 35950859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolutionarily conserved requirement for core binding factor beta in the assembly of the human immunodeficiency virus/simian immunodeficiency virus Vif-cullin 5-RING E3 ubiquitin ligase.
    Han X; Liang W; Hua D; Zhou X; Du J; Evans SL; Gao Q; Wang H; Viqueira R; Wei W; Zhang W; Yu XF
    J Virol; 2014 Mar; 88(6):3320-8. PubMed ID: 24390335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel HIV-1 inhibitor that blocks viral replication and rescues APOBEC3s by interrupting vif/CBFβ interaction.
    Duan S; Wang S; Song Y; Gao N; Meng L; Gai Y; Zhang Y; Wang S; Wang C; Yu B; Wu J; Yu X
    J Biol Chem; 2020 Oct; 295(43):14592-14605. PubMed ID: 32817167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell differentiation factor CBF-β regulates HIV-1 Vif-mediated evasion of host restriction.
    Zhang W; Du J; Evans SL; Yu Y; Yu XF
    Nature; 2011 Dec; 481(7381):376-9. PubMed ID: 22190036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis of antagonism of human APOBEC3F by HIV-1 Vif.
    Hu Y; Desimmie BA; Nguyen HC; Ziegler SJ; Cheng TC; Chen J; Wang J; Wang H; Zhang K; Pathak VK; Xiong Y
    Nat Struct Mol Biol; 2019 Dec; 26(12):1176-1183. PubMed ID: 31792451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining HIV-1 Vif residues that interact with CBFβ by site-directed mutagenesis.
    Matsui Y; Shindo K; Nagata K; Io K; Tada K; Iwai F; Kobayashi M; Kadowaki N; Harris RS; Takaori-Kondo A
    Virology; 2014 Jan; 449():82-7. PubMed ID: 24418540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular requirements for bovine immunodeficiency virus Vif-mediated inactivation of bovine APOBEC3 proteins.
    Zhang W; Wang H; Li Z; Liu X; Liu G; Harris RS; Yu XF
    J Virol; 2014 Nov; 88(21):12528-40. PubMed ID: 25142583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Core Binding Factor β Protects HIV, Type 1 Accessory Protein Viral Infectivity Factor from MDM2-mediated Degradation.
    Matsui Y; Shindo K; Nagata K; Yoshinaga N; Shirakawa K; Kobayashi M; Takaori-Kondo A
    J Biol Chem; 2016 Nov; 291(48):24892-24899. PubMed ID: 27758855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the interaction of full-length HIV-1 Vif protein with its key regulator CBFβ and CRL5 E3 ubiquitin ligase components.
    Zhou X; Evans SL; Han X; Liu Y; Yu XF
    PLoS One; 2012; 7(3):e33495. PubMed ID: 22479405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a tripartite interaction between the N-terminus of HIV-1 Vif and CBFβ that is critical for Vif function.
    Desimmie BA; Smith JL; Matsuo H; Hu WS; Pathak VK
    Retrovirology; 2017 Mar; 14(1):19. PubMed ID: 28302150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin F/FBXO1 Interacts with HIV-1 Viral Infectivity Factor (Vif) and Restricts Progeny Virion Infectivity by Ubiquitination and Proteasomal Degradation of Vif Protein through SCF
    Augustine T; Chaudhary P; Gupta K; Islam S; Ghosh P; Santra MK; Mitra D
    J Biol Chem; 2017 Mar; 292(13):5349-5363. PubMed ID: 28184007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of Enhanced HIV Restriction by Virion Coencapsidated Cytidine Deaminases APOBEC3F and APOBEC3G.
    Ara A; Love RP; Follack TB; Ahmed KA; Adolph MB; Chelico L
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a Conserved Interface of Human Immunodeficiency Virus Type 1 and Feline Immunodeficiency Virus Vifs with Cullin 5.
    Gu Q; Zhang Z; Gertzen CGW; Häussinger D; Gohlke H; Münk C
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29263270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of Vif-Derived Peptide Inhibitors with Anti-HIV-1 Activity by Interrupting Vif-CBFβ Interaction.
    Gai Y; Duan S; Wang S; Liu K; Yu X; Yang C; Li G; Zhou Y; Yu B; Wu J; Wang C; Yu X
    Viruses; 2024 Mar; 16(4):. PubMed ID: 38675833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 and HIV-2 Vif interact with human APOBEC3 proteins using completely different determinants.
    Smith JL; Izumi T; Borbet TC; Hagedorn AN; Pathak VK
    J Virol; 2014 Sep; 88(17):9893-908. PubMed ID: 24942576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degradation-Independent Inhibition of APOBEC3G by the HIV-1 Vif Protein.
    Stupfler B; Verriez C; Gallois-Montbrun S; Marquet R; Paillart JC
    Viruses; 2021 Apr; 13(4):. PubMed ID: 33916704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maedi-visna virus Vif protein uses motifs distinct from HIV-1 Vif to bind zinc and the cofactor required for A3 degradation.
    Knecht KM; Hu Y; Rubene D; Cook M; Ziegler SJ; Jónsson SR; Xiong Y
    J Biol Chem; 2021; 296():100045. PubMed ID: 33465707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural perspectives on HIV-1 Vif and APOBEC3 restriction factor interactions.
    Azimi FC; Lee JE
    Protein Sci; 2020 Feb; 29(2):391-406. PubMed ID: 31518043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.